Patient-centric care benefits all

Against the backdrop of rising healthcare costs, value-based care (VBC) is the sustainable alternative to the current fee-for-service model, according to Dr Ernst Marais, COO of the ICON Group.


Hybrid imaging: The future looks bright(er) for oncology patients

Imaging has become an indispensable tool in cancer research, clinical trials and medical practice. Over the past few decades, there has been a huge increase in the number of molecular imaging technologies and their applications.

How to prevent CAT

Cancer-associated thromboembolism (CAT) is the second most common cause of mortality in cancer patients (>40%). CAT also complicates the course of malignancy, particularly in the setting of medical and surgical anticancer treatments.

Advanced and metastatic breast cancer: Is metronomic chemotherapy the answer?

In the 1940s the average five-year survival rate for all breast cancer (BC) patients was 53%. As a result of advances in cancer treatment, survival rates in patients with BC have increased dramatically.

NSCLC: Latest treatment approaches

Globally, lung cancer occurred in about 2.1 million patients in 2018, with an estimated mortality of 1.8 million. This makes it the leading cause of cancer death in the world, including South Africa.

When men get cancer

Although all men are at risk of complications due to prostate enlargement, those who have a family history of prostate cancer should be made aware that they are at high risk. In South Africa the lifetime risk for prostate cancer in men is one in 19.

5 fertility preservation options for cancer patients

Over the past few decades, there has been a sharp increase in cancer survivors due to advancements in cancer therapeutics and early detection. Many of these survivors are in their reproductive years, and planning a family is at the top of their priority list.

New advances in head and neck squamous cell carcinoma

Lose teeth, oral abscesses and inexplicable ear ache might be signs and of head and neck squamous cell carcinoma (HNSCC), says radiation oncologist, Dr Robert de Müelenaere of De Müelenaere Oncology. HNSCC ranks sixth among the most common cancers worldwide with over 500 000 new cases reported each year.

Latest breast cancer trends

Breast cancer treatment has evolved over the last 50 years, from a disease treated mainly by surgeons to now being a showcase for multidisciplinary team management.

Who and how often should you screen for cervical cancer?

The United States Preventive Services Task Force (USPSTF) published their updated recommendation statement on screening for cervical cancer (CC) in the August issue of the Journal of the American Medical Association.

New hope for men with mCRPC

Androgen deprivation therapy has been the mainstay of treatment for advanced and metastatic prostate cancer, but the treatment is not curative and most men progress to mCRPC.

Hodgkin lymphoma guideline 2018

Specialist Forum December 2018 CPD 3 of 3: With modern treatment strategies, 80%–90% of patients with Hodgkin lymphoma achieve permanent remission, according to the European Society for Medical Oncology’s new HL guideline.

Management of post-radical prostatectomy ED

MEDICAL CHRONICLE NOVEMBER 2 of 3: Radical prostatectomy is a commonly performed procedure for the treatment of localised prostate cancer. One of the long-term complications is erectile dysfunction (ED).

Prostate cancer: Salvage options for failure post-primary radiotherapy

Radiotherapy for localised prostate cancer is a standard option, but unfortunately a significant number of patients will experience prostate-specific antigen failure after treatment.

Breast cancer: the importance of early diagnosis and treatment

MEDICAL CHRONICLE OCTOBER CPD 2 of 4: Breast cancer is the most common of all cancers in women, with the lifetime risk of getting breast cancer in South African women being 1 out of every 26.

Changing the oncology landscape

Immunotherapy has dramatically changed the oncology landscape and improved patient outcomes, but dealing with immune-related adverse events (irAEs) can be challenging.

Cervical cancer: HPV and screening


A practical approach to oral and dermatological toxicities caused by anticancer therapies

Advances in the treatment of potentially life-threatening diseases such as cancer, are often accompanied by side effects, which can severely affect patients’ quality of life (QOL). As a result, some patients discontinue treatment.

Read More

MSD announces local regulatory approval of new oncology drug

In recognising the impact that Pembrolizumab would have in oncology treatment, MSD received regulatory approval by the Medicines Control Council (now South African Health Products Regulatory Authority) in South Africa.

Rare but there

Male breast cancer is an uncommon disease that has been the focus of limited research. Because this disease is rare, no randomised trials have been possible.

Read More